Neogenomics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
NeoGenomics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 21, 2026, to elect directors, approve executive compensation, amend its equity incentive plan, and ratify its accounting firm.
NASDAQ
NeoGenomics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
NeoGenomics is asking stockholders to approve an amendment to its 2023 Equity Incentive Plan to increase the share reserve, establish minimum vesting periods, and prohibit liberal share recycling.
NASDAQ
NeoGenomics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
NeoGenomics has scheduled its 2024 Annual Meeting of Stockholders for May 23, 2024, featuring proposals on director elections, executive compensation, an employee stock purchase plan amendment, and auditor ratification.